Acute leukaemia in patients treated for Hodgkin's disease

No abstract is available for this paper.

• Publication year

  1984

• Venue

  British Journal of Haematology

• Publication date

  1984-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.1984.tb06057.xPMID 6466571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International System for Human Cytogenetic Nomenclature

  2020cited by this paper
• The incidence and characteristics of acute myeloid leukaemia arising in Hodgkin's disease.

  2009cited by this paper
• Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II. Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients

  1984cited by this paper
• Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease.

  1983cited by this paper
• Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.

  1982cited by this paper
• Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.

  1982cited by this paper
• Second malignancies associated with chemotherapeutic agents.

  1982cited by this paper
• Acute myeloid leukemia following treatment of hodgkin's disease. A review

  1982cited by this paper
• Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study.

  1982cited by this paper
• Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease.

  1981cited by this paper
• Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Clinical and cytogenetic characteristics and results of in vitro culture of bone marrow and HLA typing.

  1981cited by this paper
• The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky memorial lecture

  1981cited by this paper
• [Induced leukemias. Cytogenetical and cytological aspects. Comparison with primitive leukemias (author's transl)].

  1981cited by this paper
• Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.

  1980cited by this paper
• Second malignancy in patients treated for Hodgkin's disease

  1980cited by this paper
• Post‐therapeutic acute leukemia

  1979cited by this paper
• Hematologic neoplasia in patients treated for Hodgkin's disease.

  1977cited by this paper
• Multiple primary cancer risk after therapy for Hodgkin's disease

  1977cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

  1976cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• Second malignancies complicating Hodgkin's disease in remission.

  1975cited by this paper
• Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP

  1975cited by this paper
• Combination chemotherapy in the treatment of advanced Hodgkin's disease.

  1975cited by this paper
• Carcinogenesis by Cancer Chemotherapeutic Agents: Second Malignancies Complicating Hodgkin’s Disease in Remission

  1974cited by this paper
• Nonlymphomatous malignant tumors complicating Hodgkin's disease. Possible association with intensive therapy.

  1972cited by this paper
• Report of the Committee on Hodgkin's Disease Staging Classification.

  1971cited by this paper
• Human bone marrow colony growth in agar‐gel

  1970cited by this paper
• Combination chemotherapy in the treatment of advanced Hodgkin's disease.

  1970cited by this paper
• Report of the Nomenclature Committee

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Hodgkin’s Disease

  1933cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.

  2014cites this paper
• Therapy-related acute promyelocytic leukemia: a systematic review

  2013cites this paper
• Persistent genomic instability in peripheral blood lymphocytes from hodgkin lymphoma survivors

  2012cites this paper
• A case of Burkitt lymphoma-L3ALL with t(8;14) translocation, developed 10 years after Hodgkin's disease.

  2009cites this paper
• Therapy-induced myelodysplasia and secondary leukaemia.

  2009cites this paper
• Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?

  2008cites this paper
• Intermediate stage Hodgkin's disease: preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy.

  2004cites this paper
• Therapy-related acute promyelocytic leukemia.

  2003cites this paper
• Acute myeloid leukemia and myelodysplastic syndrome in children treated for cancer: comparison with primary presentation.

  2002cites this paper
• Long‐term results of 60 patients with pathologic stage I & IIA Hodgkin's disease treated with exclusive mantle radiation therapy

  1999cites this paper
• The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.

  1998cites this paper
• The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.

  1998cites this paper
• Analysis of the risk of solid tumor following Hodgkin's disease.

  1997cites this paper
• Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease

  1997cites this paper
• Acute promyelocytic leukemia after treatment of malignant glioma in a patient with von Recklinghausen's disease: case report and review of the literature.

  1996cites this paper
• Staging Laparotomy in the Management of Hodgkin's Disease: Is It Still Necessary?

  1996cites this paper
• Acute promyelocytic leukaemia with t(15;17) following treatment of Hodgkin's disease--a report of 4 cases.

  1995cites this paper
• Using multistage models to describe radiation-induced leukaemia

  1995cites this paper
• Mutagenicity and carcinogenicity of topoisomerase-interactive agents

  1994cites this paper
• International Commission for Protection Against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents.

  1994cites this paper
• Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.

  1994cites this paper
• Hodgkin's disease in adults. Part II.

  1993cites this paper
• Acute leukemia after the treatment of Hodgkin's disease.

  1993cites this paper
• Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.

  1993cites this paper
• Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma.

  1992cites this paper
• Secondary acute non-lymphoblastic leukemia in two children following treatment with a cis-diamminedichloroplatinum-II-based regimen for osteosarcoma.

  1992cites this paper
• Therapy-related acute promyelocytic leukemia: a report on 16 cases.

  1992cites this paper
• Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure.

  1992cites this paper
• Hodgkin's disease.

  1992cites this paper
• Increased risk of second cancers in managing Hodgkin's disease: the 20-year Leiden experience

  1992influential citation
• Simultaneous Occurrence of Monoclonal Gammopathy and Acute Secondary Leukemia with Overexpression of P-Glycoprotein

  1992cites this paper
• Late Relapse in Hodgkin's Disease: Report of Five Cases and a Review of the Literature.

  1991cites this paper
• Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.

  1991cites this paper
• Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.

  1991cites this paper
• Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.

  1991cites this paper
• Cytogenetic studies in Hodgkin's disease.

  1990cites this paper
• Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: analysis of a series of 94 patients. Pierre and Marie Curie Group (GPMC).

  1990cites this paper
• Improved survival in advanced Hodgkin's disease with the use of combined modality therapy.

  1990cites this paper
• Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP.

  1990cites this paper
• [Second malignant tumor in children. Report of 22 cases].

  1990cites this paper
• Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.

  1990cites this paper
• Ischaemic colitis as a complication of colonoscopy.

  1990cites this paper
• Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.

  1990cites this paper
• Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas

  1990cites this paper
• Second neoplasms in Hodgkin's disease: current controversies.

  1989cites this paper
• Myelodysplasia with bone marrow lymphocytosis and fibrosis mimicking recurrent Hodgkin's disease.

  1989cites this paper
• MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.

  1989cites this paper
• The role of restaging laparotomy in Hodgkin's disease.

  1989cites this paper
• Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.

  1989cites this paper
• Secondary myelodysplasia/leukemia complex.

  1989cites this paper
• Subsequent development of acute non‐lymphocytic leukemia in patients treated for Hodgkin's disease

  1988cites this paper
• Hodgkin's disease: subsequent primary cancers in relation to treatment.

  1988cites this paper
• Morphologic, Immunologic, and Cytogenetic Characteristics of Secondary Acute Unclassifiable Leukemia in Hodgkin's Disease

  1988cites this paper
• Treatment‐related leukemia in Hodgkin's disease: A multi‐institution study on 75 cases

  1987cites this paper
• B‐cell chronic lymphatic leukemia in Hodgkin's disease. A report of two patients with unusual chromosome features

  1987cites this paper
• RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE: Relation to Age, Cumulative Dose of Alkylating Agents, and Time from Chemotherapy

  1987cites this paper
• Major complications and causes of death in patients treated for Hodgkin's disease.

  1987cites this paper
• Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease

  1987cites this paper
• Radical treatment of Hodgkin disease with radiation therapy: results of a 15-year clinical trial. The 1985 Erskine lecture.

  1987cites this paper
• Therapy-related acute non-lymphoid leukemia.

  1987cites this paper
• Secondary Acute non Lymphoid Leukemia in Patients Treated for non Hodgkin's Lymphoma: No Risk of Therapy-Related Anll after Provecip Schedule

  1987cites this paper
• Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.

  1987cites this paper
• Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.

  1986cites this paper
• Secondary myelodysplastic syndromes and leukaemias.

  1986cites this paper
• Concomitant illness in patients treated for Hodgkin's disease.

  1986cites this paper
• Acute leukemia occurring in a primary neoplasia (secondary leukemia). A Review of biological, epidemiological and clinical aspects.

  1986cites this paper
• Hodgkin's disease (HD): a historical perspective.

  1986cites this paper
• Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.

  1986cites this paper
• Hodgkin's disease: long-term effects of therapy.

  1986cites this paper
• Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem.

  1986cites this paper
• Chromosomal changes in secondary leukemias of childhood and young adulthood.

  1986cites this paper
• Biphenotypic leukemia with unusual chromosomal translocation in a patient treated for melanoma.

  1986cites this paper
• Translocation (9;11)(p21;q23) in a child with acute monoblastic leukemia following 2 1/2 years after successful chemotherapy for neuroblastoma.

  1986cites this paper
• Hodgkin's disease (HD): A historical perspective☆

  1986cites this paper
• Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with Idarubicin.

  1985cites this paper
• SECONDARY ACUTE MYELOID LEUKAEMIA: A HETEROGENEOUS ENTITY?

  1985cites this paper